Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Hepatitis

Free Subscription Articles published in Virology Retrieve available abstracts of 53 articles: HTML format

Single Articles

June 2021
1. DEB B, Uddin A, Chakraborty S
   Analysis of codon usage of Horseshoe Bat Hepatitis B virus and its host.
   Virology. 2021;561:69-79.
   PubMed     Abstract available
   
   
   February 2021
2. KANG X, Chen X, He Y, Guo D, et al
   Corrigendum to "DDB1 is a cellular substrate of NS3/4A protease and required for hepatitis C virus replication" [Virology 435 (2013) 385-394].
   Virology. 2021 Feb 8. pii: S0042-6822(21)00021.
   PubMed    
   
   
   November 2020
3. YU R, Tan S, Dan Y, Lu Y, et al
   Effect of SARS-CoV-2 coinfection was not apparent on the dynamics of chronic hepatitis B infection.
   Virology. 2020;553:131-134.
   PubMed     Abstract available
   
   
   August 2020
4. DATTA S
   Excavating new facts from ancient Hepatitis B virus sequences.
   Virology. 2020;549:89-99.
   PubMed     Abstract available
   
   
   June 2020
5. LAFONTAINE E, Miller CM, Permaul N, Martin ET, et al
   Ribosomal protein RACK1 enhances translation of poliovirus and other viral IRESs.
   Virology. 2020;545:53-62.
   PubMed     Abstract available
   
   
   February 2020
6. LIU Z, Behloul N, Baha S, Wei W, et al
   Role of the C-terminal cysteines in virus-like particle formation and oligomerization of the hepatitis E virus ORF2 truncated proteins.
   Virology. 2020;544:1-11.
   PubMed     Abstract available
   
   
   
7. SITU J, Wang W, Long F, Yang W, et al
   Hepatitis E viral infection causes testicular damage in mice.
   Virology. 2020;541:150-159.
   PubMed     Abstract available
   
   
   November 2019
8. BANNISTER E, Sozzi V, Mason H, Locarnini S, et al
   Analysis of the in vitro replication phenotype of African hepatitis B virus (HBV) genotypes and subgenotypes present in Australia identifies marked differences in DNA and protein expression.
   Virology. 2019;540:97-103.
   PubMed     Abstract available
   
   
   October 2019
9. FORBERG K, Rodgers MA, Dawson GJ, Sauleda S, et al
   Human pegivirus 2 exhibits minimal geographic and temporal genetic diversity.
   Virology. 2019;539:69-79.
   PubMed     Abstract available
   
   
   
10. WANG F, Shen F, Wang Y, Li Z, et al
    Residues Asn118 and Glu119 of hepatitis B virus X protein are critical for HBx-mediated inhibition of RIG-I-MAVS signaling.
    Virology. 2019;539:92-103.
    PubMed     Abstract available
    
    
    September 2019
11. MEJER N, Galli A, Ramirez S, Fahnoe U, et al
    Ribavirin inhibition of cell-culture infectious hepatitis C genotype 1-3 viruses is strain-dependent.
    Virology. 2019;540:132-140.
    PubMed     Abstract available
    
    
    July 2019
12. SHIOTA T, Li TC, Nishimura Y, Yoshizaki S, et al
    Integrin alpha3 is involved in non-enveloped hepatitis E virus infection.
    Virology. 2019;536:119-124.
    PubMed     Abstract available
    
    
    
13. ZHANG Y, Zhao X, Zou J, Yuan Z, et al
    Dual role of the amphipathic helix of hepatitis C virus NS5A in the viral polyprotein cleavage and replicase assembly.
    Virology. 2019;535:283-296.
    PubMed     Abstract available
    
    
    
14. LU G, Ou J, Sun Y, Wu L, et al
    Natural recombination of equine hepacivirus subtype 1 within the NS5A and NS5B genes.
    Virology. 2019;533:93-98.
    PubMed     Abstract available
    
    
    March 2019
15. ITO H, Kanbe A, Hara A, Ishikawa T, et al
    Induction of humoral and cellular immune response to HBV vaccine can be up-regulated by STING ligand.
    Virology. 2019;531:233-239.
    PubMed     Abstract available
    
    
    
16. LUKASH T, Freitas N, Menne S, Gudima SO, et al
    Down-regulation of hepatitis delta virus super-infection in the woodchuck model.
    Virology. 2019;531:100-113.
    PubMed     Abstract available
    
    
    February 2019
17. JALAL PJ, King BJ, Saeed A, Adedeji Y, et al
    Elevated serum activity of MBL and ficolin-2 as biomarkers for progression to hepatocellular carcinoma in chronic HCV infection.
    Virology. 2019;530:99-106.
    PubMed     Abstract available
    
    
    January 2019
18. SUZUKI R, Matsuda M, Shimoike T, Watashi K, et al
    Activation of protein kinase R by hepatitis C virus RNA-dependent RNA polymerase.
    Virology. 2019;529:226-233.
    PubMed     Abstract available
    
    
    
19. WALTERS AW, Kujawa MR, Albe JR, Reed DS, et al
    Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats.
    Virology. 2019;526:173-179.
    PubMed     Abstract available
    
    
    December 2018
20. XUE W, Zhao Q, Li P, Zhang R, et al
    Identification and characterization of a novel nanobody against duck hepatitis A virus type 1.
    Virology. 2018;528:101-109.
    PubMed     Abstract available
    
    
    November 2018
21. GRIERSON SS, McGowan S, Cook C, Steinbach F, et al
    Molecular and in vitro characterisation of hepatitis E virus from UK pigs.
    Virology. 2018;527:116-121.
    PubMed     Abstract available
    
    
    
22. SHALABY RE, Iram S, Oropeza CE, McLachlan A, et al
    Peroxisome proliferator-activated receptor gamma coactivator family members competitively regulate hepatitis b virus biosynthesis.
    Virology. 2018;526:214-221.
    PubMed     Abstract available
    
    
    
23. ZHANG J, Zong L, Wang Y, Li C, et al
    Core gene insertion in hepatitis B virus genotype G functions at both the encoded amino acid sequence and RNA structure levels to stimulate core protein expression.
    Virology. 2018;526:203-213.
    PubMed     Abstract available
    
    
    September 2018
24. TSUGE M, Hiraga N, Zhang Y, Yamashita M, et al
    Endoplasmic reticulum-mediated induction of interleukin-8 occurs by hepatitis B virus infection and contributes to suppression of interferon responsiveness in human hepatocytes.
    Virology. 2018;525:48-61.
    PubMed     Abstract available
    
    
    
25. LIU C, Xu G, Gao Z, Zhou Z, et al
    The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency.
    Virology. 2018;522:168-176.
    PubMed     Abstract available
    
    
    August 2018
26. ZHANG H, Qiao L, Luo G
    Characterization of apolipoprotein C1 in hepatitis C virus infection and morphogenesis.
    Virology. 2018;524:1-9.
    PubMed     Abstract available
    
    
    
27. GALLEGO I, Gregori J, Soria ME, Garcia-Crespo C, et al
    Resistance of high fitness hepatitis C virus to lethal mutagenesis.
    Virology. 2018;523:100-109.
    PubMed     Abstract available
    
    
    July 2018
28. HUMES D, Ramirez S, Jensen TB, Li YP, et al
    Recombinant hepatitis C virus genotype 5a infectious cell culture systems expressing minimal JFH1 NS5B sequences permit polymerase inhibitor studies.
    Virology. 2018;522:177-192.
    PubMed     Abstract available
    
    
    May 2018
29. WU Q, Li Z, Liu Q
    An important role of SREBP-1 in HBV and HCV co-replication inhibition by PTEN.
    Virology. 2018;520:94-102.
    PubMed     Abstract available
    
    
    
30. SOZZI V, Shen F, Chen J, Colledge D, et al
    In vitro studies identify a low replication phenotype for hepatitis B virus genotype H generally associated with occult HBV and less severe liver disease.
    Virology. 2018;519:190-196.
    PubMed     Abstract available
    
    
    April 2018
31. KRAPCHEV VB, Rychlowska M, Chmielewska A, Zimmer K, et al
    Recombinant Flag-tagged E1E2 glycoproteins from three hepatitis C virus genotypes are biologically functional and elicit cross-reactive neutralizing antibodies in mice.
    Virology. 2018;519:33-41.
    PubMed     Abstract available
    
    
    March 2018
32. BI X, Tong S
    Impact of immune escape mutations and N-linked glycosylation on the secretion of hepatitis B virus virions and subviral particles: Role of the small envelope protein.
    Virology. 2018;518:358-368.
    PubMed     Abstract available
    
    
    
33. LI J, Feng S, Liu X, Guo M, et al
    Identification of nucleotides in the 5'UTR and amino acids substitutions that are essential for the infectivity of 5'UTR-NS5A recombinant of hepatitis C virus genotype 1b (strain Con1).
    Virology. 2018;518:253-263.
    PubMed     Abstract available
    
    
    February 2018
34. HUANG K, Chen J, Xu R, Jiang X, et al
    Molecular evolution of hepatitis C virus in China: A nationwide study.
    Virology. 2018;516:210-218.
    PubMed     Abstract available
    
    
    January 2018
35. VAN DE LAAR TJ, Van Gaever VA, Swieten PV, Muylaert A, et al
    Phylogenetic analysis reveals three distinct epidemiological profiles in Dutch and Flemish blood donors with hepatitis B virus infection.
    Virology. 2018;515:243-249.
    PubMed     Abstract available
    
    
    December 2017
36. MANICKAM C, Martinot AJ, Jones RA, Varner V, et al
    Hepatic immunopathology during occult hepacivirus re-infection.
    Virology. 2017;512:48-55.
    PubMed     Abstract available
    
    
    November 2017
37. CAMUS G, Xu S, Han B, Lu J, et al
    Establishment of robust HCV genotype 4d, 5a, and 6a replicon systems.
    Virology. 2017;514:134-141.
    PubMed     Abstract available
    
    
    
38. MESALAM AA, Desombere I, Farhoudi A, Van Houtte F, et al
    Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.
    Virology. 2017;514:30-41.
    PubMed     Abstract available
    
    
    October 2017
39. ELIZALDE MM, Sevic I, Gonzalez Lopez Ledesma MM, Campos RH, et al
    Human hepatocytes apoptosis induced by replication of hepatitis B virus subgenotypes F1b and F4: Role of basal core promoter and preCore mutations.
    Virology. 2017;513:160-167.
    PubMed     Abstract available
    
    
    
40. NAKANO T, Takahashi M, Takahashi K, Nagashima S, et al
    Hepatitis E virus subtype 3f strains isolated from Japanese hepatitis patients with no history of travel to endemic areas - The origin analyzed by molecular evolution.
    Virology. 2017;513:146-152.
    PubMed     Abstract available
    
    
    
41. AHN HS, Han SH, Kim YH, Park BJ, et al
    Adverse fetal outcomes in pregnant rabbits experimentally infected with rabbit hepatitis E virus.
    Virology. 2017;512:187-193.
    PubMed     Abstract available
    
    
    August 2017
42. WU Q, Li Z, Liu Q
    Treatment with PTEN-Long protein inhibits hepatitis C virus replication.
    Virology. 2017;511:1-8.
    PubMed     Abstract available
    
    
    
43. QUE L, Liu G, Kitamura K, Wakae K, et al
    Molecular characterization of AID-mediated reduction of hepatitis B virus transcripts.
    Virology. 2017;510:281-288.
    PubMed     Abstract available
    
    
    July 2017
44. LIN YM, Chen BF
    A putative hepatitis B virus splice variant associated with chronic hepatitis and liver cirrhosis.
    Virology. 2017;510:224-233.
    PubMed     Abstract available
    
    
    
45. MA J, Li T, Han X, Yuan H, et al
    Discovery and mechanism of action of Novel Baicalein modified derivatives as potent antihepatitis agent.
    Virology. 2017;507:199-205.
    PubMed     Abstract available
    
    
    June 2017
46. RYDELL GE, Prakash K, Norder H, Lindh M, et al
    Hepatitis B surface antigen on subviral particles reduces the neutralizing effect of anti-HBs antibodies on hepatitis B viral particles in vitro.
    Virology. 2017;509:67-70.
    PubMed     Abstract available
    
    
    
47. JU H, Liu H, Tian ZB, Jiang YP, et al
    Association of polymorphisms in key Th-17 immune response genes with HBeAg-positive chronic hepatitis B susceptibility and response to PEG-IFNa-2alpha.
    Virology. 2017;509:35-41.
    PubMed     Abstract available
    
    
    April 2017
48. BIEGEL JM, Henderson E, Cox EM, Bonenfant G, et al
    Cellular DEAD-box RNA helicase DDX6 modulates interaction of miR-122 with the 5' untranslated region of hepatitis C virus RNA.
    Virology. 2017;507:231-241.
    PubMed     Abstract available
    
    
    
49. EYRE NS, Aloia AL, Joyce MA, Chulanetra M, et al
    Sensitive luminescent reporter viruses reveal appreciable release of hepatitis C virus NS5A protein into the extracellular environment.
    Virology. 2017;507:20-31.
    PubMed     Abstract available
    
    
    
50. KHERA L, Paul C, Kaul R
    Hepatitis C Virus E1 protein promotes cell migration and invasion by modulating cellular metastasis suppressor Nm23-H1.
    Virology. 2017;506:110-120.
    PubMed     Abstract available
    
    
    February 2017
51. RODGERS MA, Vallari AS, Harris B, Yamaguchi J, et al
    Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon.
    Virology. 2017;504:141-151.
    PubMed     Abstract available
    
    
    January 2017
52. GALLAGHER JR, Torian U, McCraw DM, Harris AK, et al
    Characterization of the disassembly and reassembly of the HBV glycoprotein surface antigen, a pliable nanoparticle vaccine platform.
    Virology. 2017;502:176-187.
    PubMed     Abstract available
    
    
    September 2016
53. PINKHAM C, An S, Lundberg L, Bansal N, et al
    The role of signal transducer and activator of transcription 3 in Rift Valley fever virus infection.
    Virology. 2016;496:175-85.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: